Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: Shield hypothesis

Infection and Immunity

Volumn 72, Issue 12, 2004, Pages 6846-6851

  Simmons, Warren L ^a   Denison, Amy M ^b   Dybvig, Kevin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GRAMICIDIN D; POLYPEPTIDE; POLYSTYRENE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VSA PROTEIN; VSAA PROTEIN; VSAG PROTEIN; VSAI PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CHANNEL GATING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG SENSITIVITY; ERYTHROCYTE; GENETIC CONSERVATION; GENETIC VARIABILITY; HYPOTHESIS; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY; TANDEM REPEAT;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL ADHESION; COMPLEMENT ACTIVATION; GRAMICIDIN; GUINEA PIGS; HEMOLYSIS; MYCOPLASMA PULMONIS; TANDEM REPEAT SEQUENCES;

EID: 9244232330     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.12.6846-6851.2004     Document Type: Article

References (34)

1. Alitalo, A., T. Meri, L. Ramo, T. S. Jokiranta, T. Heikkila, I. J. T. Seppala, J. Oksi, M. Viljanen, and S. Meri. 2001. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect. Immun. 69:3685-3691.
2. Bhugra, B., L. L. Voelker, N. Zou, H. Yu, and K. Dybvig. 1995. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol. Microbiol. 18:703-714.
3. Cartner, S. C., J. R. Lindsey, J. Gibbs-Erwin, G. H. Cassell, and J. W. Simecka. 1998. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect. Immun. 66:3485-3491.
4. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
5. Citti, C., and R. Rosengarten. 1997. Mycoplasma genetic variation and its implication for pathogenesis. Wien. Klin. Wochenschr. 109:562-568.
6. Davidson, M. K., J. R. Lindsey, R. F. Parker, J. G. Tully, and G. H. Cassell. 1988. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect. Immun. 56:2156-2162.
7. Davis, J. K., R. B. Thorp, R. F. Parker, H. White, D. Dziedzic, J. D'Arcy, and G. H. Cassell. 1986. Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect. Immun. 54:194-201.
8. Dybvig, K., J. Alderete, H. L. Watson, and G. H. Cassell. 1988. Adsorption of mycoplasma virus P1 to host cells. J. Bacteriol. 170:4373-4375.
9. Dybvig, K., C. T. French, and L. L. Voelker. 2000. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J. Bacteriol. 182:4343-4347.
10. Dybvig, K., J. W. Simecka, H. L. Watson, and G. H. Cassell. 1989. High-frequency variation in Mycoplasma pulmonis colony size. J. Bacteriol. 171: 5165-5168.
11. Dybvig, K., and L. L. Voelker. 1996. Molecular biology of mycoplasmas. Annu. Rev. Microbiol. 50:25-57.
12. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
13. Furr, P. M., and D. Taylor-Robinson. 1993. Factors influencing the ability of different mycoplasmas to colonize the genital tract of hormone-treated female mice. Int. J. Exp. Pathol. 74:97-101.
14. Gumulak-Smith, J., A. Teachman, A. H. Tu, J. W. Simecka, J. R. Lindsey, and K. Dybvig. 2001. Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol. Microbiol. 40:1037-1044.
15. Joiner, K. A., C. H. Hammer, E. J. Brown, R. J. Cole, and M. M. Frank. 1982. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J. Exp. Med. 155:797-808.
16. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Köhl, L. Wahl, D. Kuperman, S.Germer, D. Aud, G. Peltz, and M. Wills-Karp. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221-226.
17. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987-1995.
18. Neeleman, C., S. P. Geelen, P. C. Aerts, M. R. Daha, T. E. Mollnes, J. J. Roord, G. Posthuma, H. van Dijk, and A. Fleer. 1999. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect. Immun. 67:4517-4524.
19. Nir-Paz, R., M.-C. Prevost, P. Nicolas, A. Blanchard, and H. Wroblewski. 2002. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob. Agents Chemother. 46:1218-1225.
20. Rautemma, R., and S. Meri. 1999. Complement-resistance mechanisms of bacteria. Microbes Infect. 1:785-794.
21. Regal, J. F. 1997. Role of the complement system in pulmonary disorders. Immunopharmacology 38:17-25.
22. Ren, B., A. J. Szala, T. Orlanda, S. K. Hollingshead, and D. E. Briles. 2003. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect. Immun. 71:75-85.
23. Sahu, A., and J. D. Lambris. 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180:35-48.
24. Shen, X., J. Gumulak, H. Yu, C. T. French, N. Zou, and K. Dybvig. 2002. Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J. Bacteriol. 182:2900-2908.
25. Simmons, W. L., and K. Dybvig. 2003. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement, hemadsorption, and adherence to polystyrene. Infect. Immun. 71:5733-5738.
26. Simmons, W. L., C. Zuhua, J. I. Glass, J. W. Simecka, G. H. Cassell, and H. L. Watson. 1996. Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect. Immun. 64:472-479.
27. Sitaraman, R., A. M. Denison, and K. Dybvig. 2002. A unique, bifunctional site-specific DNA recombinase from Mycoplasma pulmonis. Mol. Microbiol. 46:1033-1040.
28. Teachman, A. M., C. T. French, H. Yu, W. L. Simmons, and K. Dybvig. 2002. Gene transfer in Mycoplasma pulmonis. J. Bacteriol. 184:947-951.
29. Walters, D. M., P. N. Breysse, B. Schofield, and M. Willis-Karp. 2002. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 27:413-418.
30. Ward, C. K., and T. J. Inzana. 1994. Resistance of Actinobaciilus pleuropneumoniae to bacterial antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide. J. Immunol. 153:2110-2121.
31. Watson, H. L., D. K. Blalock, and G. H. Cassell. 1988. Characterization of the variable V-1 antigen of Mycoplasma pulmonis, p. 529-534. In G. Stanek, G. H. Cassell, J. G. Tully, and R. F. Whitcomb (ed.), Recent advances in mycoplasmology, vol. 20. Gustav Fischer Verlag, Stuttgart, Germany.
32. Watson, H. L., L. S. McDaniel, D. K. Blalock, M. T. Fallon, and G. H. Cassell. 1988. Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis. Infect. Immun. 56:1358-1363.
33. Watson, H. L., X. Zheng, and G. H. Cassell. 1993. Structural variations and phenotypic switching of mycoplasmal antigens. Clin. Infect. Dis. 17:S183-S186.
34. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5́-exon. J. Biol. Chem. 265:2435-2440.